Guggenheim analyst Vamil Divan reiterated a Buy rating and $227.00 price target on Johnson & Johnson (NYSE: JNJ).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE